Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Chemify Ltd.

Headquarters: Glasgow, United Kingdom
Year Founded: 2019
Status: Private

BioCentury | Mar 1, 2025
Management Tracks

Orbus names co-founder, COO Levin president

Plus: Michael Bell becomes CTO of Chemify, and updates from Genbio AI and Epivax
BioCentury | Jan 11, 2025
Management Tracks

Faces in new places ahead of JPM: Rubin joining Guggenheim

Week’s management moves include new venture partners at Frazier and updates from Beigene, Intellia and more
BioCentury | Aug 15, 2024
Management Tracks

CFO Kemula leaving CureVac

Plus: Chemify hires CBO to realize commercial ambitions and more from Biocartis and Estrella
BioCentury | Sep 14, 2023
Regulation

Sept. 13 Quick Takes: Madrigal gets March PDUFA date for NASH therapy

Plus: Rocket parlays gene therapy update into $175M raise and updates from DalCor, Mironid, Crinetics, Shionogi, Hasten, Dewpoint and Orchid
BioCentury | Aug 2, 2023
Finance

Aug. 2 Quick Takes: CG Oncology raises $105M crossover round

Plus: Emerson Collective spins out Yosemite with $200M cancer fund, first commercial patient receives Sarepta’s DMD gene therapy, and more
Items per page:
1 - 5 of 5